Loading clinical trials...
Loading clinical trials...
An Open, Multi-center, Prospective and Retrospective Observational Study to Evaluate the Long-term Safety and Effectiveness of Growth Hormone (Eutropin Inj. / Eutropin Plus Inj.) Treatment With GHD, TS, CRF, SGA, ISS and PWS in Children
Conditions
Locations
1
South Korea
Seoul National University Hospital
Seoul, South Korea
Start Date
January 1, 2012
Primary Completion Date
December 31, 2032
Completion Date
December 31, 2032
Last Updated
February 21, 2021
NCT02417740
NCT07333521
NCT00227253
NCT06780514
NCT06325618
NCT06227468
Lead Sponsor
LG Chem
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions